234 related articles for article (PubMed ID: 21682887)
1. Differential effect of CLK SR Kinases on HIV-1 gene expression: potential novel targets for therapy.
Wong R; Balachandran A; Mao AY; Dobson W; Gray-Owen S; Cochrane A
Retrovirology; 2011 Jun; 8():47. PubMed ID: 21682887
[TBL] [Abstract][Full Text] [Related]
2. Opposing roles of CLK SR kinases in controlling HIV-1 gene expression and latency.
Dahal S; Clayton K; Been T; Fernet-Brochu R; Ocando AV; Balachandran A; Poirier M; Maldonado RK; Shkreta L; Boligan KF; Guvenc F; Rahman F; Branch D; Bell B; Chabot B; Gray-Owen SD; Parent LJ; Cochrane A
Retrovirology; 2022 Aug; 19(1):18. PubMed ID: 35986377
[TBL] [Abstract][Full Text] [Related]
3. Regulation of influenza A virus mRNA splicing by CLK1.
Artarini A; Meyer M; Shin YJ; Huber K; Hilz N; Bracher F; Eros D; Orfi L; Keri G; Goedert S; Neuenschwander M; von Kries J; Domovich-Eisenberg Y; Dekel N; Szabadkai I; Lebendiker M; Horváth Z; Danieli T; Livnah O; Moncorgé O; Frise R; Barclay W; Meyer TF; Karlas A
Antiviral Res; 2019 Aug; 168():187-196. PubMed ID: 31176694
[TBL] [Abstract][Full Text] [Related]
4. Characterization of novel inhibitors of HIV-1 replication that function via alteration of viral RNA processing and rev function.
Wong RW; Balachandran A; Haaland M; Stoilov P; Cochrane A
Nucleic Acids Res; 2013 Nov; 41(20):9471-83. PubMed ID: 23945945
[TBL] [Abstract][Full Text] [Related]
5. Human CDC2-like kinase 1 (CLK1): a novel target for Alzheimer's disease.
Jain P; Karthikeyan C; Moorthy NS; Waiker DK; Jain AK; Trivedi P
Curr Drug Targets; 2014 May; 15(5):539-50. PubMed ID: 24568585
[TBL] [Abstract][Full Text] [Related]
6. An activator of G protein-coupled receptor and MEK1/2-ERK1/2 signaling inhibits HIV-1 replication by altering viral RNA processing.
Wong RW; Balachandran A; Cheung PK; Cheng R; Pan Q; Stoilov P; Harrigan PR; Blencowe BJ; Branch DR; Cochrane A
PLoS Pathog; 2020 Feb; 16(2):e1008307. PubMed ID: 32069328
[TBL] [Abstract][Full Text] [Related]
7. Akt2 regulation of Cdc2-like kinases (Clk/Sty), serine/arginine-rich (SR) protein phosphorylation, and insulin-induced alternative splicing of PKCbetaII messenger ribonucleic acid.
Jiang K; Patel NA; Watson JE; Apostolatos H; Kleiman E; Hanson O; Hagiwara M; Cooper DR
Endocrinology; 2009 May; 150(5):2087-97. PubMed ID: 19116344
[TBL] [Abstract][Full Text] [Related]
8. Hypoxia leads to significant changes in alternative splicing and elevated expression of CLK splice factor kinases in PC3 prostate cancer cells.
Bowler E; Porazinski S; Uzor S; Thibault P; Durand M; Lapointe E; Rouschop KMA; Hancock J; Wilson I; Ladomery M
BMC Cancer; 2018 Apr; 18(1):355. PubMed ID: 29606096
[TBL] [Abstract][Full Text] [Related]
9. Combination of Clk family kinase and SRp75 modulates alternative splicing of Adenovirus E1A.
Yomoda J; Muraki M; Kataoka N; Hosoya T; Suzuki M; Hagiwara M; Kimura H
Genes Cells; 2008 Mar; 13(3):233-44. PubMed ID: 18298798
[TBL] [Abstract][Full Text] [Related]
10. The Clk/Sty protein kinase phosphorylates SR splicing factors and regulates their intranuclear distribution.
Colwill K; Pawson T; Andrews B; Prasad J; Manley JL; Bell JC; Duncan PI
EMBO J; 1996 Jan; 15(2):265-75. PubMed ID: 8617202
[TBL] [Abstract][Full Text] [Related]
11. Clk/STY (cdc2-like kinase 1) and Akt regulate alternative splicing and adipogenesis in 3T3-L1 pre-adipocytes.
Li P; Carter G; Romero J; Gower KM; Watson J; Patel NA; Cooper DR
PLoS One; 2013; 8(1):e53268. PubMed ID: 23308182
[TBL] [Abstract][Full Text] [Related]
12. Digoxin suppresses HIV-1 replication by altering viral RNA processing.
Wong RW; Balachandran A; Ostrowski MA; Cochrane A
PLoS Pathog; 2013 Mar; 9(3):e1003241. PubMed ID: 23555254
[TBL] [Abstract][Full Text] [Related]
13. Dual effect of the SR proteins ASF/SF2, SC35 and 9G8 on HIV-1 RNA splicing and virion production.
Jacquenet S; Decimo D; Muriaux D; Darlix JL
Retrovirology; 2005 May; 2():33. PubMed ID: 15907217
[TBL] [Abstract][Full Text] [Related]
14. Kinase domain insertions define distinct roles of CLK kinases in SR protein phosphorylation.
Bullock AN; Das S; Debreczeni JE; Rellos P; Fedorov O; Niesen FH; Guo K; Papagrigoriou E; Amos AL; Cho S; Turk BE; Ghosh G; Knapp S
Structure; 2009 Mar; 17(3):352-62. PubMed ID: 19278650
[TBL] [Abstract][Full Text] [Related]
15. Identification of small molecule modulators of HIV-1 Tat and Rev protein accumulation.
Balachandran A; Wong R; Stoilov P; Pan S; Blencowe B; Cheung P; Harrigan PR; Cochrane A
Retrovirology; 2017 Jan; 14(1):7. PubMed ID: 28122580
[TBL] [Abstract][Full Text] [Related]
16. ANP32A and ANP32B are key factors in the Rev-dependent CRM1 pathway for nuclear export of HIV-1 unspliced mRNA.
Wang Y; Zhang H; Na L; Du C; Zhang Z; Zheng YH; Wang X
J Biol Chem; 2019 Oct; 294(42):15346-15357. PubMed ID: 31444273
[TBL] [Abstract][Full Text] [Related]
17. The HIV-1 Tat Protein Enhances Splicing at the Major Splice Donor Site.
Mueller N; Pasternak AO; Klaver B; Cornelissen M; Berkhout B; Das AT
J Virol; 2018 Jul; 92(14):. PubMed ID: 29743356
[TBL] [Abstract][Full Text] [Related]
18. hnRNP E1 and E2 have distinct roles in modulating HIV-1 gene expression.
Woolaway K; Asai K; Emili A; Cochrane A
Retrovirology; 2007 Apr; 4():28. PubMed ID: 17451601
[TBL] [Abstract][Full Text] [Related]
19. Manipulation of alternative splicing by a newly developed inhibitor of Clks.
Muraki M; Ohkawara B; Hosoya T; Onogi H; Koizumi J; Koizumi T; Sumi K; Yomoda J; Murray MV; Kimura H; Furuichi K; Shibuya H; Krainer AR; Suzuki M; Hagiwara M
J Biol Chem; 2004 Jun; 279(23):24246-54. PubMed ID: 15010457
[TBL] [Abstract][Full Text] [Related]
20. SGC-CLK-1: A chemical probe for the Cdc2-like kinases CLK1, CLK2, and CLK4.
Tiek D; Wells CI; Schröder M; Song X; Alamillo-Ferrer C; Goenka A; Iglesia R; Lu M; Hu B; Kwarcinski F; Sintha P; de Silva C; Hossain MA; Picado A; Zuercher W; Zutshi R; Knapp S; Riggins RB; Cheng SY; Drewry DH
Curr Res Chem Biol; 2023; 3():. PubMed ID: 38009092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
